GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » IM Cannabis Corp (XCNQ:IMCC) » Definitions » EV-to-FCF

IM Cannabis (XCNQ:IMCC) EV-to-FCF : 8.97 (As of Dec. 12, 2024)


View and export this data going back to 1980. Start your Free Trial

What is IM Cannabis EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, IM Cannabis's Enterprise Value is C$24.65 Mil. IM Cannabis's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2024 was C$2.75 Mil. Therefore, IM Cannabis's EV-to-FCF for today is 8.97.

The historical rank and industry rank for IM Cannabis's EV-to-FCF or its related term are showing as below:

XCNQ:IMCC' s EV-to-FCF Range Over the Past 10 Years
Min: -58.63   Med: -4.7   Max: 8.97
Current: 8.97

During the past 13 years, the highest EV-to-FCF of IM Cannabis was 8.97. The lowest was -58.63. And the median was -4.70.

XCNQ:IMCC's EV-to-FCF is ranked better than
80.98% of 552 companies
in the Drug Manufacturers industry
Industry Median: 25.86 vs XCNQ:IMCC: 8.97

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2024-12-12), IM Cannabis's stock price is C$3.45. IM Cannabis's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 was C$-5.800. Therefore, IM Cannabis's PE Ratio (TTM) for today is At Loss.


IM Cannabis EV-to-FCF Historical Data

The historical data trend for IM Cannabis's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IM Cannabis EV-to-FCF Chart

IM Cannabis Annual Data
Trend Apr13 Apr14 Apr16 Apr17 Apr18 Apr19 Dec20 Dec21 Dec22 Dec23
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only -9.82 -36.96 -7.88 -1.41 -2.01

IM Cannabis Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.08 -2.01 -7.02 4.01 6.73

Competitive Comparison of IM Cannabis's EV-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, IM Cannabis's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


IM Cannabis's EV-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, IM Cannabis's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where IM Cannabis's EV-to-FCF falls into.



IM Cannabis EV-to-FCF Calculation

IM Cannabis's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=24.654/2.75
=8.97

IM Cannabis's current Enterprise Value is C$24.65 Mil.
IM Cannabis's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$2.75 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


IM Cannabis  (XCNQ:IMCC) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

IM Cannabis's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=3.45/-5.800
=At Loss

IM Cannabis's share price for today is C$3.45.
IM Cannabis's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-5.800.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


IM Cannabis EV-to-FCF Related Terms

Thank you for viewing the detailed overview of IM Cannabis's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


IM Cannabis Business Description

Traded in Other Exchanges
Address
Central District, Kibbutz Glil Yam, ISR, 4690500
IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority is from Israel.
Executives
Karl Grywacheski Director or Senior Officer of Insider or Subsidiary (other than in 4,5,6)
Rafael Gabay 10% Security Holder